Gospodinov D, Hadzhiilieva L, Gerasimov N. Incretin axis in cardiometabolic disease: molecular and systemic mechanisms of GLP-1 and GIP therapies. MR. 2026;62(5):5-11. Accessed September 14, 2026. https://journals.mu-sofia.bg/index.php/mr/article/view/1128